Shanghai Hongmai Medical Technology Co., Ltd. announced that it will receive funding in an equity round on December 10, 2020. The transaction will include participation from returning investor, Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHSE:688016) to retain 100% stake in the company. The transaction has been approved in the 11th meeting of the 1st board of supervisors of the investor.